Mercedes F. G.
- Country
- Spain
- Department
- N/A
Research Overview
- Evaluation of Budoprutug (TNT119) Efficacy and Safety in Patients with Systemic Lupus Erythematosus
- A Phase 3, Randomized, Double-Blind Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who are on a Stable Background of Methotrexate (MTX) and Who Have an Inadequate Response to MTX (MTX-IR)
- Phase 2 Randomized Double‑Blind Placebo‑Controlled Trial of Subcutaneous Daxdilimab (with background prednisone) in Adults with Dermatomyositis or Anti‑Synthetase Myositis
Data & Insights
Has run more than one trial at 163 of 370 partner sites.
Specializations
Lupus Research Focus
The investigator specializes in various forms of lupus erythematosus, conducting research across multiple manifestations of the condition, including systemic lupus erythematosus (SLE), cutaneous lupus erythematosus, and discoid lupus erythematosus.
- Systemic Lupus Management
- Cutaneous Manifestations
- Novel Therapeutic Approaches
Autoimmune Disorders
The investigator focuses on treating complex autoimmune conditions, particularly Sjögren's syndrome and idiopathic inflammatory myopathies, including both dermatomyositis and polymyositis.
- Inflammatory Muscle Disorders
- Sjögren's Disease Management
- Systemic Autoimmune Conditions
Rheumatic Conditions
The investigator has expertise in treating rheumatoid arthritis with particular attention to patients who show inadequate response to conventional treatments. Their work includes evaluation of combination therapies and alternative treatment strategies.
- Treatment-Resistant Cases
- Combination Therapy Approaches
- Disease Activity Management
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.